With JALM, the Association for Diagnostics & Laboratory Medicine (ADLM, formerly AACC) empowers lab professionals to discover new adaptive solutions to patient health problems and drive innovation in the field. JALM expands on the scope of cutting-edge research in Clinical Chemistry by focusing on translational or applied laboratory medicine studies.
JALM considers submissions on laboratory methods, evidence-based laboratory medicine, flow cytometry, management, best practices, appropriate test utilization, critical care, and pediatric testing. Additionally, it provides a forum for discussion of policy and regulatory issues that impact the field.
ADLM Professional, Transitional, and Trainee members receive access to JALM as a free member benefit.
This article discusses the detection of hemolysis by clinical laboratories from both American and European perspectives and shows how, within the clinical lab, no recommendations are mandatory and implementation of the hemolysis index testing is not universal.
Researchers developed an approach using for safe and effective screening of patients with possible acute myocardial infarction.
Listen to podcast episodes from experts in the field, keeping you up to date with the latest research on all areas of laboratory medicine.
Reported interindividual variation in eGFR performance is significantly larger than any potential benefit derived from race coefficients.
Learn more about advertising opportunities in JALM.
